A carregar...
Mesothelin as a target for chimeric antigen receptor-modified T cells as anticancer therapy
Mesothelin is a promising target for immune-based therapy, specifically for mesothelioma and pancreatic and ovarian cancers that have high levels of mesothelin expression. Many preclinical and clinical studies that target tumors with high mesothelin expression with antibodies, immunotoxins, antibody...
Na minha lista:
| Publicado no: | Immunotherapy |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5619020/ https://ncbi.nlm.nih.gov/pubmed/26973126 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt.16.4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|